Skip to main content
PALI logo

Palisade Bio, Inc.

PALINASDAQHealthcareBiotechnology

$1.41Today:- (-)1Y −11.49%

As of Oct 16, 2026 close

Market cap
$325.53M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$1.32$2.86
Volume (live)
-
Avg. volume (3M)
3.40M

Palisade Bio (PALI) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Palisade Bio reported total assets of $134.34M and total liabilities of $4.96M. Shareholders' equity was $129.38M, up 1626.9% from $7.49M a year earlier. Total debt stood at $71.00K against $133.38M in cash and short-term investments, a net cash position of $133.31M. That puts debt-to-equity at 0.00, compared with 0.01 a year earlier.

Palisade Bio Balance Sheet Analysis

Values in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Palisade Bio, Inc. (PALI) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Current Assets
Cash and Cash Equivalents133.399.8212.4312.3810.500.715.115.796.67
Short-Term Investments0.000.010.000.000.000.020.000.005.00
Cash & Short-Term Investments133.399.8212.4312.3810.500.735.115.7911.67
Accounts Receivable0.260.020.151.440.150.000.020.360.37
Inventory0.000.000.000.000.000.000.000.000.00
Other Current Assets0.570.670.750.911.010.170.510.360.40
Total Current Assets134.2210.4913.3314.7311.510.905.656.5112.45
Non-Current Assets
Property, Plant & Equipment (Net)0.000.090.210.310.110.280.240.090.17
Long-Term Investments0.060.000.000.030.000.000.000.300.37
Intangible Assets0.000.000.000.000.000.000.670.760.88
Other Non-Current Assets0.070.300.520.690.891.840.030.020.01
Total Non-Current Assets0.120.390.721.031.012.120.941.181.44
Total Assets134.3410.8814.0515.7612.513.026.587.6813.88
Current Liabilities
Accounts Payable0.771.110.701.761.322.540.820.830.88
Short-Term Debt0.070.080.280.190.091.220.140.000.00
Current Portion of Long-Term Debt-0.080.160.090.091.05---
Accrued Liabilities2.021.961.611.060.974.33---
Deferred Revenue0.000.000.000.000.000.000.00-4.500.00
Other Current Liabilities3.801.961.611.060.784.330.260.220.64
Total Current Liabilities4.643.242.593.012.508.081.221.051.51
Non-Current Liabilities
Long-Term Debt0.000.000.090.210.000.210.150.540.00
Other Non-Current Liabilities0.330.150.060.062.651.830.080.053.85
Total Non-Current Liabilities0.330.150.150.272.652.040.230.583.85
Total Liabilities4.963.392.743.285.1510.121.461.635.37
Stockholders' Equity
Common Stock1.590.030.090.030.000.030.040.180.15
Retained Earnings-152.73-135.94-121.51-109.19-94.64-68.03-221.98-213.62-208.70
Accumulated Other Comprehensive Income0.000.000.000.000.000.00-0.010.000.00
Additional Paid-in Capital280.51143.41132.72121.64102.0051.40227.07219.48217.05
Shares Outstanding159.642.970.820.400.22----
Total Stockholders' Equity129.387.4911.3112.487.37-7.105.136.058.52
Total Liabilities & Equity134.3410.8814.0515.7612.513.026.587.6813.88

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Palisade Bio Balance Sheet

How much debt does Palisade Bio have?

Palisade Bio had total debt of $71.00K as of Dec 31, 2025, against $133.38M in cash and short-term investments. Its debt-to-equity ratio was 0.00. Total debt was $79.00K a year earlier.

What are Palisade Bio's total assets?

Palisade Bio reported total assets of $134.34M as of Dec 31, 2025, up 1134.8% from $10.88M a year earlier. Total liabilities were $4.96M.

What is Palisade Bio's shareholders' equity?

Palisade Bio's shareholders' equity was $129.38M as of Dec 31, 2025, or about $0.81 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition